← Human Trials & Peer-Reviewed Studies
Effects of oral environment stabilization procedures on counts of Candida spp. in children.
Plain-language guide to PMID 15107915 (2004): randomized controlled trial of Glass Ionomer Cements and Zinc Oxide-Eugenol Cement in 30 boys.
Key Facts
- PMID
- 15107915
- Journal
- Pesquisa odontologica brasileira = Brazilian oral research
- Year
- 2004
- Study type
- Randomized Controlled Trial
- Authors
- do Rego MA et al. (3 authors)
- DOI
- 10.1590/s1517-74912003000400007
What This Study Did, in Plain Language
What Was Tested
Researchers studied Glass Ionomer Cements and Zinc Oxide-Eugenol Cement in this randomized controlled trial publication.
The aim of this study was thus to ascertain the effects of oral environment stabilization procedures with glass ionomer and zinc oxide-eugenol cements on counts of Candida spp. in the oral cavity of children.
For this purpose, oral rinses of sterile phosphate-buffered saline were initially collected from 30 boys and 30 girls, positive for Candida in the saliva and aged from 4 to 10 years.
Why It Was Studied
Data on the initial quantity of CFU/ml of Candida were obtained.
Then, the children were randomly divided into two groups and oral environment stabilization procedures were performed using zinc oxide-eugenol cement or glass ionomer cement.
Who Took Part
The abstract describes 30 boys taking part.
The age groups tagged for this paper are young children and children, both men and women.
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Glass Ionomer Cements study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
The subject headings attached to it are Candida, Candidiasis, Oral, Colony Count, Microbial, Dental Caries, Glass Ionomer Cements, Mouth and Streptococcus mutans.
What This Means in Plain Language
The paper is a randomized study of Glass Ionomer Cements and Zinc Oxide-Eugenol Cement in 30 boys.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2004 (Pesquisa odontologica brasileira = Brazilian oral research), a journal based in Brazil.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.